BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 21, 2007
View Archived Issues
Bavarian Nordic Raising $82M In Discounted Rights Offering
Bavarian Nordic A/S is set to raise gross proceeds of DKK465 million (US$82 million) from a fully underwritten rights issue directed at current shareholders. (BioWorld International)
Read More
Ark Gets OKs To Advance Vitor Into Phase III Studies
Read More
Receptor May Hold Key To Treating Myeloma
Read More
Basilea Pharma Hits New High On Alitretinoin Phase III Data
Read More
Celogos Licenses Myoblast Tool For Stress Urinary Incontinence
Read More
Other News To Note
Read More
CeNeS Pain Compound Shows Good Results, With One Glitch
Read More
New French Biosimilar Controls Get Warm Welcome In Europe
Read More
EU Launches Study To Boost Biotech Competitiveness
Read More